Adicet Bio Analyst Price Targets - Benzinga

Adicet Bio Inc

ACETNASDAQ

Trade with Public

Trade with Public

$6.47

-0.03-0.46%

Últ. Act.: Oct 5, 4:28 PM

$6.49

-0.01-0.15%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

Adicet Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adicet Bio (ACET).

Price Target Range — 10 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$52Upside to Avg. PT+703.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	Wedbush	Robert Driscoll	PT Raise	Outperform	$25→$28
Sep 28, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$27→$34
Sep 18, 2026	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$27
Aug 6, 2026	Guggenheim	Yatin Suneja	PT Cut	Buy	$100→$90
May 5, 2026	Jefferies	Anthea Li	Assumes	Buy	$8→$19
Mar 23, 2026	HC Wainwright & Co.	Robert Burns	PT Cut	Buy	$50→$27
Mar 13, 2026	Guggenheim	Yatin Suneja	PT Cut	Buy	$128→$100
Jan 21, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$9→$50
Jan 6, 2026	Canaccord Genuity	John Newman	Maintained	Buy	$128→$18
Nov 7, 2025	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$4→$9
Oct 8, 2025	Guggenheim	Yatin Suneja	PT Raise	Buy	$7→$8
Sep 19, 2025	Guggenheim	Yatin Suneja	Maintained	Buy	$7
Jul 23, 2025	HC Wainwright & Co.	Robert Burns	Assumes	Buy	$4
Mar 21, 2025	Guggenheim	Yatin Suneja	Maintained	Buy	$7
Mar 7, 2025	Citizens Capital Markets	Reni Benjamin	Maintained	Market Perform	—
Mar 7, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Feb 27, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Feb 6, 2025	JMP Securities	Reni Benjamin	Maintained	Market Perform	—
Feb 5, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Dec 19, 2024	HC Wainwright & Co.	Edward White	Maintained	Neutral	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Maintains Outperform on Adicet Bio, Raises Price Target to $28

Wedbush analyst Robert Driscoll maintains Adicet Bio (NASDAQ:ACET) with a Outperform and raises the price target from $25 to $28.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $34

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $27 to $34.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $27 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $27 price target.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $100 to $90.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $50 to $27.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $128 to $100.

Benzinga Newsdesk